Optimizing the Use of Novel Therapies for Patients with Diffuse Large B-Cell Lymphoma (DLBCL)

A CME/MOC-Accredited Interactive Grand Rounds Series

Date
Friday, May 22, 2026

Program Schedule — Central Time
7:30 AM – 8:00 AM — Registration and Breakfast
8:00 AM – 9:00 AM — Educational Program

Location
The University of Oklahoma Health Campus
1100 N Lindsay Ave
Oklahoma City, OK 73104

Meeting Room
Conference Room: SCB 240

Brad S Kahl

Faculty

Brad S Kahl

MD

Washington University School of Medicine, St Louis, Missouri

Professor of Medicine

Siteman Cancer Center, St Louis, Missouri

Director, Lymphoma Program

Registration

This activity is supported by educational grants from Bristol Myers Squibb, Genentech, a member of the Roche Group, and Genmab US Inc.

Not an official event of the 2026 ASCO® Annual Meeting. Not sponsored, endorsed, or accredited by ASCO®, Association for Clinical Oncology, or Conquer Cancer®, the ASCO Foundation.